← All indications
Pyelonephritis
Inflammation of the KIDNEY involving the renal parenchyma (the NEPHRONS); KIDNEY PELVIS; and KIDNEY CALICES. It is characterized by ABDOMINAL PAIN; FEVER; NAUSEA; VOMITING; and occasionally DIARRHEA.
Subtype terms (2)
More specific conditions that are subtypes of Pyelonephritis in the MeSH hierarchy.
Drugs by status
Approved for this indication (9)
Phase 4 trials (8)
Phase 3 trials (22)
Phase 2 trials (7)
Phase 1 trials (1)
Other trials (4)
Organizations
Organization Involved with Phase 4 Indications (13)
- University of Manitoba
- Sykehuset i Vestfold HF
- The Hospital of Vestfold
- University of Oslo
- University of Trieste
- Janssen Pharmaceutica NV
- Free University of Brussels
- University of Nice Sophia Antipolis
- University of Paris
- DUPUYTREN HOSPITAL
- Ghent University
- Assistance Publique - Hôpitaux de Paris
- University Clermont Auvergne
Organization Involved with Phase 3 Indications (38)
- Zavante Therapeutics
- Peninsula Pharmaceuticals
- Achaogen, Inc.
- The Medicines Company
- AstraZeneca
- Merck
- Cubist
- Hamad Medical Corporation
- Sihuan Pharmaceutical Holdings Group Ltd.
- Spero Therapeutics
- Sponsor GmbH
- VenatoRx Pharmaceuticals, Inc.
- Wockhardt
- Shahid Beheshti University of Medical Sciences
- Aligarh Muslim University
- King George's Medical University
- Postgraduate Institute of Medical Education and Research
- Sir Ganga Ram Hospital
- University of Tehran
- University of Alberta
- Wayne State University
- All India Institute of Medical Sciences
- Medpace, Inc.
- Isfahan University
- Hamedan University of Medical Sciences
- K.L.E.S Dr. Prabhakar Kore Hospital & Medical research Centre
- SP Medical College, Bikaner
- MV Hospital and Research Center
- Deenanath Mangeshkar Hospital & Research Centre
- Department of Health and Human Services
- +8 more
Organization Involved with Phase 2 Indications (10)
Organization Involved with Other Experimental Indications (1)